ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Circulating Tumor Cells and Cancer Stem Cells Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-30P9123
Home | Market Reports | Health| Health Foundations & Medical Research
Global Circulating Tumor Cells and Cancer Stem Cells Market Insights and Forecast to 2028
BUY CHAPTERS

Global Circulating Tumor Cells and Cancer Stem Cells Market Research Report 2025

Code: QYRE-Auto-30P9123
Report
September 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
QIAGEN Hannover
Aviva Biosciences
Epic Sciences
Apocell Inc
Cynvenio Biosystems
Fluxion Biosciences
Rarecells
Janssen Diagnostics
Celltraffix Inc
Silicon Biosystems
Advanced Cell Diagnostics

Circulating Tumor Cells and Cancer Stem Cells Market Size

The global market for Circulating Tumor Cells and Cancer Stem Cells was valued at US$ 19140 million in the year 2024 and is projected to reach a revised size of US$ 50240 million by 2031, growing at a CAGR of 15.0% during the forecast period.

Circulating Tumor Cells and Cancer Stem Cells Market

Circulating Tumor Cells and Cancer Stem Cells Market

Circulating tumor cells (CTCs) are tumor cells that detach from the primary tumor and travel in the bloodstream, spreading from the original tumor to other locations, leading to cancer metastasis. These cells exist in peripheral blood of cancer patients and detection of CTCs can help to determine the process of metastasis. In contrast with other blood cells, the number of CTCs is very rare in blood which makes them difficult to detect.
Cancer stem cells (CSCs) are cancer cells that have all the classical properties of normal stem cells. Specifically, they are able to both give rise to more copies of themselves and to give rise to all cell types found in the cancer.
The major players in global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market include Janssen, Qiagen, Advanced Cell Diagnostics, etc. North America and Europe are main markets, they occupy about 65% of the global market. CellSearch is the main type, with a share about 70%. Breast Cancer Diagnosis and Treatment, Colorectal Cancer Diagnosis and Treatment are main applications, which hold a share about 60%.
This report aims to provide a comprehensive presentation of the global market for Circulating Tumor Cells and Cancer Stem Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Circulating Tumor Cells and Cancer Stem Cells.
The Circulating Tumor Cells and Cancer Stem Cells market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Circulating Tumor Cells and Cancer Stem Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Circulating Tumor Cells and Cancer Stem Cells companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Circulating Tumor Cells and Cancer Stem Cells Market Report

Report Metric Details
Report Name Circulating Tumor Cells and Cancer Stem Cells Market
Accounted market size in year US$ 19140 million
Forecasted market size in 2031 US$ 50240 million
CAGR 15.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Cell Enrichment
  • Cell Detection
  • CTC Analysis
Segment by Application
  • Hospital
  • NSC
  • Medical Research Institute
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company QIAGEN Hannover, AVIVA Biosciences, Epic Sciences, ApoCell, Cynvenio Biosystems, Fluxion Biosciences, Rarecells, Janssen Diagnostics, CellTraffix, Silicon Biosystems, Advanced Cell Diagnostics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Circulating Tumor Cells and Cancer Stem Cells company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Circulating Tumor Cells and Cancer Stem Cells Market growing?

Ans: The Circulating Tumor Cells and Cancer Stem Cells Market witnessing a CAGR of 15.0% during the forecast period 2025-2031.

What is the Circulating Tumor Cells and Cancer Stem Cells Market size in 2031?

Ans: The Circulating Tumor Cells and Cancer Stem Cells Market size in 2031 will be US$ 50240 million.

Who are the main players in the Circulating Tumor Cells and Cancer Stem Cells Market report?

Ans: The main players in the Circulating Tumor Cells and Cancer Stem Cells Market are QIAGEN Hannover, AVIVA Biosciences, Epic Sciences, ApoCell, Cynvenio Biosystems, Fluxion Biosciences, Rarecells, Janssen Diagnostics, CellTraffix, Silicon Biosystems, Advanced Cell Diagnostics

What are the Application segmentation covered in the Circulating Tumor Cells and Cancer Stem Cells Market report?

Ans: The Applications covered in the Circulating Tumor Cells and Cancer Stem Cells Market report are Hospital, NSC, Medical Research Institute

What are the Type segmentation covered in the Circulating Tumor Cells and Cancer Stem Cells Market report?

Ans: The Types covered in the Circulating Tumor Cells and Cancer Stem Cells Market report are Cell Enrichment, Cell Detection, CTC Analysis

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circulating Tumor Cells and Cancer Stem Cells Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cell Enrichment
1.2.3 Cell Detection
1.2.4 CTC Analysis
1.3 Market by Application
1.3.1 Global Circulating Tumor Cells and Cancer Stem Cells Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 NSC
1.3.4 Medical Research Institute
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Circulating Tumor Cells and Cancer Stem Cells Market Perspective (2020-2031)
2.2 Global Circulating Tumor Cells and Cancer Stem Cells Growth Trends by Region
2.2.1 Global Circulating Tumor Cells and Cancer Stem Cells Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Circulating Tumor Cells and Cancer Stem Cells Historic Market Size by Region (2020-2025)
2.2.3 Circulating Tumor Cells and Cancer Stem Cells Forecasted Market Size by Region (2026-2031)
2.3 Circulating Tumor Cells and Cancer Stem Cells Market Dynamics
2.3.1 Circulating Tumor Cells and Cancer Stem Cells Industry Trends
2.3.2 Circulating Tumor Cells and Cancer Stem Cells Market Drivers
2.3.3 Circulating Tumor Cells and Cancer Stem Cells Market Challenges
2.3.4 Circulating Tumor Cells and Cancer Stem Cells Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Circulating Tumor Cells and Cancer Stem Cells Players by Revenue
3.1.1 Global Top Circulating Tumor Cells and Cancer Stem Cells Players by Revenue (2020-2025)
3.1.2 Global Circulating Tumor Cells and Cancer Stem Cells Revenue Market Share by Players (2020-2025)
3.2 Global Circulating Tumor Cells and Cancer Stem Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Circulating Tumor Cells and Cancer Stem Cells Revenue
3.4 Global Circulating Tumor Cells and Cancer Stem Cells Market Concentration Ratio
3.4.1 Global Circulating Tumor Cells and Cancer Stem Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cells and Cancer Stem Cells Revenue in 2024
3.5 Global Key Players of Circulating Tumor Cells and Cancer Stem Cells Head office and Area Served
3.6 Global Key Players of Circulating Tumor Cells and Cancer Stem Cells, Product and Application
3.7 Global Key Players of Circulating Tumor Cells and Cancer Stem Cells, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Circulating Tumor Cells and Cancer Stem Cells Breakdown Data by Type
4.1 Global Circulating Tumor Cells and Cancer Stem Cells Historic Market Size by Type (2020-2025)
4.2 Global Circulating Tumor Cells and Cancer Stem Cells Forecasted Market Size by Type (2026-2031)
5 Circulating Tumor Cells and Cancer Stem Cells Breakdown Data by Application
5.1 Global Circulating Tumor Cells and Cancer Stem Cells Historic Market Size by Application (2020-2025)
5.2 Global Circulating Tumor Cells and Cancer Stem Cells Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Circulating Tumor Cells and Cancer Stem Cells Market Size (2020-2031)
6.2 North America Circulating Tumor Cells and Cancer Stem Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2020-2025)
6.4 North America Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Circulating Tumor Cells and Cancer Stem Cells Market Size (2020-2031)
7.2 Europe Circulating Tumor Cells and Cancer Stem Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2020-2025)
7.4 Europe Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Circulating Tumor Cells and Cancer Stem Cells Market Size (2020-2031)
8.2 Asia-Pacific Circulating Tumor Cells and Cancer Stem Cells Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Circulating Tumor Cells and Cancer Stem Cells Market Size by Region (2020-2025)
8.4 Asia-Pacific Circulating Tumor Cells and Cancer Stem Cells Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Circulating Tumor Cells and Cancer Stem Cells Market Size (2020-2031)
9.2 Latin America Circulating Tumor Cells and Cancer Stem Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2020-2025)
9.4 Latin America Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Circulating Tumor Cells and Cancer Stem Cells Market Size (2020-2031)
10.2 Middle East & Africa Circulating Tumor Cells and Cancer Stem Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2020-2025)
10.4 Middle East & Africa Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 QIAGEN Hannover
11.1.1 QIAGEN Hannover Company Details
11.1.2 QIAGEN Hannover Business Overview
11.1.3 QIAGEN Hannover Circulating Tumor Cells and Cancer Stem Cells Introduction
11.1.4 QIAGEN Hannover Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2020-2025)
11.1.5 QIAGEN Hannover Recent Development
11.2 AVIVA Biosciences
11.2.1 AVIVA Biosciences Company Details
11.2.2 AVIVA Biosciences Business Overview
11.2.3 AVIVA Biosciences Circulating Tumor Cells and Cancer Stem Cells Introduction
11.2.4 AVIVA Biosciences Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2020-2025)
11.2.5 AVIVA Biosciences Recent Development
11.3 Epic Sciences
11.3.1 Epic Sciences Company Details
11.3.2 Epic Sciences Business Overview
11.3.3 Epic Sciences Circulating Tumor Cells and Cancer Stem Cells Introduction
11.3.4 Epic Sciences Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2020-2025)
11.3.5 Epic Sciences Recent Development
11.4 ApoCell
11.4.1 ApoCell Company Details
11.4.2 ApoCell Business Overview
11.4.3 ApoCell Circulating Tumor Cells and Cancer Stem Cells Introduction
11.4.4 ApoCell Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2020-2025)
11.4.5 ApoCell Recent Development
11.5 Cynvenio Biosystems
11.5.1 Cynvenio Biosystems Company Details
11.5.2 Cynvenio Biosystems Business Overview
11.5.3 Cynvenio Biosystems Circulating Tumor Cells and Cancer Stem Cells Introduction
11.5.4 Cynvenio Biosystems Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2020-2025)
11.5.5 Cynvenio Biosystems Recent Development
11.6 Fluxion Biosciences
11.6.1 Fluxion Biosciences Company Details
11.6.2 Fluxion Biosciences Business Overview
11.6.3 Fluxion Biosciences Circulating Tumor Cells and Cancer Stem Cells Introduction
11.6.4 Fluxion Biosciences Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2020-2025)
11.6.5 Fluxion Biosciences Recent Development
11.7 Rarecells
11.7.1 Rarecells Company Details
11.7.2 Rarecells Business Overview
11.7.3 Rarecells Circulating Tumor Cells and Cancer Stem Cells Introduction
11.7.4 Rarecells Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2020-2025)
11.7.5 Rarecells Recent Development
11.8 Janssen Diagnostics
11.8.1 Janssen Diagnostics Company Details
11.8.2 Janssen Diagnostics Business Overview
11.8.3 Janssen Diagnostics Circulating Tumor Cells and Cancer Stem Cells Introduction
11.8.4 Janssen Diagnostics Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2020-2025)
11.8.5 Janssen Diagnostics Recent Development
11.9 CellTraffix
11.9.1 CellTraffix Company Details
11.9.2 CellTraffix Business Overview
11.9.3 CellTraffix Circulating Tumor Cells and Cancer Stem Cells Introduction
11.9.4 CellTraffix Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2020-2025)
11.9.5 CellTraffix Recent Development
11.10 Silicon Biosystems
11.10.1 Silicon Biosystems Company Details
11.10.2 Silicon Biosystems Business Overview
11.10.3 Silicon Biosystems Circulating Tumor Cells and Cancer Stem Cells Introduction
11.10.4 Silicon Biosystems Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2020-2025)
11.10.5 Silicon Biosystems Recent Development
11.11 Advanced Cell Diagnostics
11.11.1 Advanced Cell Diagnostics Company Details
11.11.2 Advanced Cell Diagnostics Business Overview
11.11.3 Advanced Cell Diagnostics Circulating Tumor Cells and Cancer Stem Cells Introduction
11.11.4 Advanced Cell Diagnostics Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2020-2025)
11.11.5 Advanced Cell Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
QIAGEN Hannover
Aviva Biosciences
Epic Sciences
Apocell Inc
Cynvenio Biosystems
Fluxion Biosciences
Rarecells
Janssen Diagnostics
Celltraffix Inc
Silicon Biosystems
Advanced Cell Diagnostics
List of Tables
 Table 1. Global Circulating Tumor Cells and Cancer Stem Cells Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Cell Enrichment
 Table 3. Key Players of Cell Detection
 Table 4. Key Players of CTC Analysis
 Table 5. Global Circulating Tumor Cells and Cancer Stem Cells Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Circulating Tumor Cells and Cancer Stem Cells Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Circulating Tumor Cells and Cancer Stem Cells Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Circulating Tumor Cells and Cancer Stem Cells Market Share by Region (2020-2025)
 Table 9. Global Circulating Tumor Cells and Cancer Stem Cells Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Circulating Tumor Cells and Cancer Stem Cells Market Share by Region (2026-2031)
 Table 11. Circulating Tumor Cells and Cancer Stem Cells Market Trends
 Table 12. Circulating Tumor Cells and Cancer Stem Cells Market Drivers
 Table 13. Circulating Tumor Cells and Cancer Stem Cells Market Challenges
 Table 14. Circulating Tumor Cells and Cancer Stem Cells Market Restraints
 Table 15. Global Circulating Tumor Cells and Cancer Stem Cells Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Circulating Tumor Cells and Cancer Stem Cells Market Share by Players (2020-2025)
 Table 17. Global Top Circulating Tumor Cells and Cancer Stem Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cells and Cancer Stem Cells as of 2024)
 Table 18. Ranking of Global Top Circulating Tumor Cells and Cancer Stem Cells Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Circulating Tumor Cells and Cancer Stem Cells Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Circulating Tumor Cells and Cancer Stem Cells, Headquarters and Area Served
 Table 21. Global Key Players of Circulating Tumor Cells and Cancer Stem Cells, Product and Application
 Table 22. Global Key Players of Circulating Tumor Cells and Cancer Stem Cells, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Circulating Tumor Cells and Cancer Stem Cells Revenue Market Share by Type (2020-2025)
 Table 26. Global Circulating Tumor Cells and Cancer Stem Cells Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Circulating Tumor Cells and Cancer Stem Cells Revenue Market Share by Type (2026-2031)
 Table 28. Global Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Circulating Tumor Cells and Cancer Stem Cells Revenue Market Share by Application (2020-2025)
 Table 30. Global Circulating Tumor Cells and Cancer Stem Cells Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Circulating Tumor Cells and Cancer Stem Cells Revenue Market Share by Application (2026-2031)
 Table 32. North America Circulating Tumor Cells and Cancer Stem Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Circulating Tumor Cells and Cancer Stem Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Circulating Tumor Cells and Cancer Stem Cells Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Circulating Tumor Cells and Cancer Stem Cells Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Circulating Tumor Cells and Cancer Stem Cells Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Circulating Tumor Cells and Cancer Stem Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Circulating Tumor Cells and Cancer Stem Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2026-2031) & (US$ Million)
 Table 47. QIAGEN Hannover Company Details
 Table 48. QIAGEN Hannover Business Overview
 Table 49. QIAGEN Hannover Circulating Tumor Cells and Cancer Stem Cells Product
 Table 50. QIAGEN Hannover Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2020-2025) & (US$ Million)
 Table 51. QIAGEN Hannover Recent Development
 Table 52. AVIVA Biosciences Company Details
 Table 53. AVIVA Biosciences Business Overview
 Table 54. AVIVA Biosciences Circulating Tumor Cells and Cancer Stem Cells Product
 Table 55. AVIVA Biosciences Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2020-2025) & (US$ Million)
 Table 56. AVIVA Biosciences Recent Development
 Table 57. Epic Sciences Company Details
 Table 58. Epic Sciences Business Overview
 Table 59. Epic Sciences Circulating Tumor Cells and Cancer Stem Cells Product
 Table 60. Epic Sciences Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2020-2025) & (US$ Million)
 Table 61. Epic Sciences Recent Development
 Table 62. ApoCell Company Details
 Table 63. ApoCell Business Overview
 Table 64. ApoCell Circulating Tumor Cells and Cancer Stem Cells Product
 Table 65. ApoCell Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2020-2025) & (US$ Million)
 Table 66. ApoCell Recent Development
 Table 67. Cynvenio Biosystems Company Details
 Table 68. Cynvenio Biosystems Business Overview
 Table 69. Cynvenio Biosystems Circulating Tumor Cells and Cancer Stem Cells Product
 Table 70. Cynvenio Biosystems Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2020-2025) & (US$ Million)
 Table 71. Cynvenio Biosystems Recent Development
 Table 72. Fluxion Biosciences Company Details
 Table 73. Fluxion Biosciences Business Overview
 Table 74. Fluxion Biosciences Circulating Tumor Cells and Cancer Stem Cells Product
 Table 75. Fluxion Biosciences Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2020-2025) & (US$ Million)
 Table 76. Fluxion Biosciences Recent Development
 Table 77. Rarecells Company Details
 Table 78. Rarecells Business Overview
 Table 79. Rarecells Circulating Tumor Cells and Cancer Stem Cells Product
 Table 80. Rarecells Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2020-2025) & (US$ Million)
 Table 81. Rarecells Recent Development
 Table 82. Janssen Diagnostics Company Details
 Table 83. Janssen Diagnostics Business Overview
 Table 84. Janssen Diagnostics Circulating Tumor Cells and Cancer Stem Cells Product
 Table 85. Janssen Diagnostics Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2020-2025) & (US$ Million)
 Table 86. Janssen Diagnostics Recent Development
 Table 87. CellTraffix Company Details
 Table 88. CellTraffix Business Overview
 Table 89. CellTraffix Circulating Tumor Cells and Cancer Stem Cells Product
 Table 90. CellTraffix Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2020-2025) & (US$ Million)
 Table 91. CellTraffix Recent Development
 Table 92. Silicon Biosystems Company Details
 Table 93. Silicon Biosystems Business Overview
 Table 94. Silicon Biosystems Circulating Tumor Cells and Cancer Stem Cells Product
 Table 95. Silicon Biosystems Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2020-2025) & (US$ Million)
 Table 96. Silicon Biosystems Recent Development
 Table 97. Advanced Cell Diagnostics Company Details
 Table 98. Advanced Cell Diagnostics Business Overview
 Table 99. Advanced Cell Diagnostics Circulating Tumor Cells and Cancer Stem Cells Product
 Table 100. Advanced Cell Diagnostics Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2020-2025) & (US$ Million)
 Table 101. Advanced Cell Diagnostics Recent Development
 Table 102. Research Programs/Design for This Report
 Table 103. Key Data Information from Secondary Sources
 Table 104. Key Data Information from Primary Sources
 Table 105. Authors List of This Report


List of Figures
 Figure 1. Circulating Tumor Cells and Cancer Stem Cells Picture
 Figure 2. Global Circulating Tumor Cells and Cancer Stem Cells Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Circulating Tumor Cells and Cancer Stem Cells Market Share by Type: 2024 VS 2031
 Figure 4. Cell Enrichment Features
 Figure 5. Cell Detection Features
 Figure 6. CTC Analysis Features
 Figure 7. Global Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Circulating Tumor Cells and Cancer Stem Cells Market Share by Application: 2024 VS 2031
 Figure 9. Hospital Case Studies
 Figure 10. NSC Case Studies
 Figure 11. Medical Research Institute Case Studies
 Figure 12. Circulating Tumor Cells and Cancer Stem Cells Report Years Considered
 Figure 13. Global Circulating Tumor Cells and Cancer Stem Cells Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Circulating Tumor Cells and Cancer Stem Cells Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Circulating Tumor Cells and Cancer Stem Cells Market Share by Region: 2024 VS 2031
 Figure 16. Global Circulating Tumor Cells and Cancer Stem Cells Market Share by Players in 2024
 Figure 17. Global Top Circulating Tumor Cells and Cancer Stem Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cells and Cancer Stem Cells as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Circulating Tumor Cells and Cancer Stem Cells Revenue in 2024
 Figure 19. North America Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Circulating Tumor Cells and Cancer Stem Cells Market Share by Country (2020-2031)
 Figure 21. United States Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Circulating Tumor Cells and Cancer Stem Cells Market Share by Country (2020-2031)
 Figure 25. Germany Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Circulating Tumor Cells and Cancer Stem Cells Market Share by Region (2020-2031)
 Figure 33. China Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Circulating Tumor Cells and Cancer Stem Cells Market Share by Country (2020-2031)
 Figure 41. Mexico Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Circulating Tumor Cells and Cancer Stem Cells Market Share by Country (2020-2031)
 Figure 45. Turkey Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. QIAGEN Hannover Revenue Growth Rate in Circulating Tumor Cells and Cancer Stem Cells Business (2020-2025)
 Figure 49. AVIVA Biosciences Revenue Growth Rate in Circulating Tumor Cells and Cancer Stem Cells Business (2020-2025)
 Figure 50. Epic Sciences Revenue Growth Rate in Circulating Tumor Cells and Cancer Stem Cells Business (2020-2025)
 Figure 51. ApoCell Revenue Growth Rate in Circulating Tumor Cells and Cancer Stem Cells Business (2020-2025)
 Figure 52. Cynvenio Biosystems Revenue Growth Rate in Circulating Tumor Cells and Cancer Stem Cells Business (2020-2025)
 Figure 53. Fluxion Biosciences Revenue Growth Rate in Circulating Tumor Cells and Cancer Stem Cells Business (2020-2025)
 Figure 54. Rarecells Revenue Growth Rate in Circulating Tumor Cells and Cancer Stem Cells Business (2020-2025)
 Figure 55. Janssen Diagnostics Revenue Growth Rate in Circulating Tumor Cells and Cancer Stem Cells Business (2020-2025)
 Figure 56. CellTraffix Revenue Growth Rate in Circulating Tumor Cells and Cancer Stem Cells Business (2020-2025)
 Figure 57. Silicon Biosystems Revenue Growth Rate in Circulating Tumor Cells and Cancer Stem Cells Business (2020-2025)
 Figure 58. Advanced Cell Diagnostics Revenue Growth Rate in Circulating Tumor Cells and Cancer Stem Cells Business (2020-2025)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Circulating Tumor Cells CTCs and Cancer Stem Cells CSCs Market Insights Forecast to 2030
Global Circulating Tumor Cells CTCs Detectors Market Research Report 2024
Global Circulating Tumor Cells Market Research Report 2025
Global Circulating Tumor Cell Detection System Market Research Report 2024
Global Circulating Tumor Cell CTC Detector Market Research Report 2024
Global CTC Detection Market Research Report 2025
Global Circulating Tumor Cell CTC Detection Market Research Report 2024
Global Free Circulating Tumor Cell Detection Market Research Report 2024
Circulating Tumor Cell Capture Instrument Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Circulating Tumor Cell CTC Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Circulating Tumor Cell Diagnostics Market Insights Forecast to 2030
Global Circulating Tumor Cell Kit Market Research Report 2024
Global Cancer Stem Cells CSCs Market Research Report 2024
Global Circulating Tumour DNA ctDNA Testing Market Research Report 2024
Circulating Tumor Cells CTC Liquid Biopsy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Circulating Tumor Cell CTC Detection Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cell free Tumor DNA Detection Market Research Report 2025
Global Liquid Biopsy Products Market Insights Forecast to 2030
Global Circulating Tumor DNA Diagnostics Market Research Report 2025
Global ctDNA Detection Kit Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions